Ping‐Fang Hu

529 total citations
20 papers, 410 citations indexed

About

Ping‐Fang Hu is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Ping‐Fang Hu has authored 20 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Epidemiology and 6 papers in Cancer Research. Recurrent topics in Ping‐Fang Hu's work include Liver Disease Diagnosis and Treatment (6 papers), Liver physiology and pathology (5 papers) and Autism Spectrum Disorder Research (4 papers). Ping‐Fang Hu is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver physiology and pathology (5 papers) and Autism Spectrum Disorder Research (4 papers). Ping‐Fang Hu collaborates with scholars based in China and United States. Ping‐Fang Hu's co-authors include Wei‐Fen Xie, Beifang Ning, Han Chen, Chuan Yin, Wei Zhong, Yong Lin, Xin Zhang, Yue-Xiang Chen, Bin Shi and Wansheng Chen and has published in prestigious journals such as Hepatology, Cancer Research and Journal of Hepatology.

In The Last Decade

Ping‐Fang Hu

20 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping‐Fang Hu China 13 217 94 94 93 65 20 410
Anal Desai United States 5 268 1.2× 37 0.4× 74 0.8× 58 0.6× 53 0.8× 5 412
Judit López‐Luque Spain 8 179 0.8× 73 0.8× 70 0.7× 37 0.4× 95 1.5× 8 368
John C. McVey United States 12 124 0.6× 151 1.6× 55 0.6× 153 1.6× 98 1.5× 27 460
Eiko Saijou Japan 7 172 0.8× 80 0.9× 28 0.3× 83 0.9× 41 0.6× 10 376
Vanessa Orsini Switzerland 6 259 1.2× 100 1.1× 49 0.5× 54 0.6× 82 1.3× 9 468
Iris Kufferath Austria 8 265 1.2× 31 0.3× 45 0.5× 53 0.6× 68 1.0× 11 396
Monika Pikiolek Switzerland 6 218 1.0× 143 1.5× 48 0.5× 62 0.7× 72 1.1× 6 453

Countries citing papers authored by Ping‐Fang Hu

Since Specialization
Citations

This map shows the geographic impact of Ping‐Fang Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐Fang Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐Fang Hu more than expected).

Fields of papers citing papers by Ping‐Fang Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping‐Fang Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐Fang Hu. The network helps show where Ping‐Fang Hu may publish in the future.

Co-authorship network of co-authors of Ping‐Fang Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Ping‐Fang Hu. A scholar is included among the top collaborators of Ping‐Fang Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping‐Fang Hu. Ping‐Fang Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jun, et al.. (2023). A pilot study on glutamate receptor and carrier gene variants and risk of childhood autism spectrum. Metabolic Brain Disease. 38(7). 2477–2488. 2 indexed citations
2.
Hu, Ping‐Fang, Xin Zeng, Wei Tang, et al.. (2021). The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study. HepatoBiliary Surgery and Nutrition. 10(6). 811–824. 19 indexed citations
3.
Huang, Hai, Ping‐Fang Hu, Liang Sun, et al.. (2021). Treatment of patients with Covid‑19 with a high dose of ulinastatin. Experimental and Therapeutic Medicine. 23(2). 121–121. 4 indexed citations
4.
Yu, Hong, et al.. (2020). Association study between genetic variants in vitamin D metabolism related genes and childhood autism spectrum disorder. Metabolic Brain Disease. 35(6). 971–978. 11 indexed citations
5.
Hu, Ping‐Fang, et al.. (2019). [A new attempt with lipoprotein lipase agonists in the treatment of nonalcoholic steatohepatitis].. PubMed. 27(7). 533–540. 1 indexed citations
6.
Wang, Peiqin, Xiaohang Wang, Wenping Xu, et al.. (2019). MicroRNA-134 deactivates hepatic stellate cells by targeting TGF-β activated kinase 1-binding protein 1. Biochemistry and Cell Biology. 97(5). 505–512. 7 indexed citations
7.
Wen, Liangzhi, Kai Ding, Ze-Rui Wang, et al.. (2018). SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression. Cancer Research. 78(16). 4680–4691. 68 indexed citations
9.
Hu, Ping‐Fang, Han Chen, Xiaohang Wang, et al.. (2018). Small intestinal hemangioma: Endoscopic or surgical intervention? A case report and review of literature. World Journal of Gastrointestinal Oncology. 10(12). 516–521. 12 indexed citations
10.
Liu, Jun, Hong Yu, Aiping Yang, et al.. (2017). Single Nucleotide Polymorphisms in SLC19A1 and SLC25A9 Are Associated with Childhood Autism Spectrum Disorder in the Chinese Han Population. Journal of Molecular Neuroscience. 62(2). 262–267. 12 indexed citations
11.
Liu, Jun, et al.. (2017). A study of single nucleotide polymorphisms in CD157, AIM2 and JARID2 genes in Han Chinese children with autism spectrum disorder. Nordic Journal of Psychiatry. 72(3). 179–183. 7 indexed citations
12.
Chen, Han, Huan Peng, Wenwu Liu, et al.. (2015). Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis. Surgery. 158(6). 1704–1713. 39 indexed citations
13.
Zhu, Changpeng, Jian Wang, Bin Shi, et al.. (2014). The Transcription Factor FOXA2 Suppresses Gastric Tumorigenesis In Vitro and In Vivo. Digestive Diseases and Sciences. 60(1). 109–117. 23 indexed citations
14.
Wang, Jian, Changpeng Zhu, Ping‐Fang Hu, et al.. (2014). FOXA2 suppresses the metastasis of hepatocellular carcinoma partially through matrix metalloproteinase-9 inhibition. Carcinogenesis. 35(11). 2576–2583. 52 indexed citations
15.
Xi, Guangjun, Ping‐Fang Hu, Cunye Qu, et al.. (2013). Induced Neural Stem Cells Generated from Rat Fibroblasts. Genomics Proteomics & Bioinformatics. 11(5). 312–319. 14 indexed citations
16.
Song, Chunyan, Xin Zeng, Siwen Chen, et al.. (2010). Sophocarpine alleviates non‐alcoholic steatohepatitis in rats. Journal of Gastroenterology and Hepatology. 26(4). 765–774. 17 indexed citations
17.
Hu, Ping‐Fang & Wei‐Fen Xie. (2009). Targeted RNA interference for hepatic fibrosis. Expert Opinion on Biological Therapy. 9(10). 1305–1312. 8 indexed citations
18.
Hu, Ping‐Fang, Han Chen, Wei Zhong, et al.. (2009). Adenovirus-mediated transfer of siRNA against PAI-1 mRNA ameliorates hepatic fibrosis in rats. Journal of Hepatology. 51(1). 102–113. 42 indexed citations
19.
Zhong, Wei, Weifeng Shen, Beifang Ning, et al.. (2009). Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats #. Hepatology. 50(5). 1524–1536. 46 indexed citations
20.
Hu, Ping‐Fang, Yingwei Zhu, Wei Zhong, et al.. (2008). Inhibition of plasminogen activator inhibitor‐1 expression by siRNA in rat hepatic stellate cells. Journal of Gastroenterology and Hepatology. 23(12). 1917–1925. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026